Tubal epithelial lesions in salpingo-oophorectomy specimens of BRCA-mutation carriers and controls

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 88-93

  Mingels, Marjanka J J M ^a   Roelofsen, Thijs ^a   Van Der Laak, Jeroen A W M ^a   De Hullu, Joanne A ^a   Van Ham, Maaike A P C ^a   Massuger, Leon F A G ^a   Bulten, Johan ^a   Bol, Mijke ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA; Fallopian tube; Hereditary ovarian carcinoma; Salpingo oophorectomy; Serous carcinoma; Tubal intraepithelial carcinoma

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER LOCALIZATION; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERINE TUBE CARCINOMA;

ADULT; AGED; CARCINOMA IN SITU; CASE-CONTROL STUDIES; COHORT STUDIES; EPITHELIUM; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; HYPERPLASIA; MIDDLE AGED; OVARIECTOMY; YOUNG ADULT;

EID: 84865684159     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.015     Document Type: Article

References (35)

1. R.E. Scully, R.H. Young, and P.B. Clement Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament Atlas of Tumor Pathology 3rd ed. Fascicle 23 1998 Armed Forces Institute of Pathology Washington DC
2. J.M. Piek, R.H. Verheijen, F.H. Menko, A.P. Jongsma, J. Weegenaar, and J.J. Gille Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition Histopathology 43 2003 26 32
3. R.R. Barakat, M.G. Federici, P.E. Saigo, M.E. Robson, K. Offit, and J. Boyd Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes Cancer 89 2000 383 390
4. M.E. Sherman, J.S. Lee, R.T. Burks, J.P. Struewing, R.J. Kurman, and P. Hartge Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis Int J Gynecol Pathol 18 1999 151 157
5. J.F. Stratton, C.H. Buckley, D. Lowe, and B.A. Ponder Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group J Natl Cancer Inst 91 1999 626 628
6. J.M. Piek, P.J. van Diest, R.P. Zweemer, P. Kenemans, and R.H. Verheijen Tubal ligation and risk of ovarian cancer Lancet 358 2001 844
7. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289
8. A. Finch, M. Beiner, J. Lubinski, H.T. Lynch, P. Moller, and B. Rosen Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation JAMA 296 2006 185 192
9. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
10. J.M. Piek, B. Torrenga, B. Hermsen, R.H. Verheijen, R.P. Zweemer, and J.J. Gille Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study Fam Cancer 2 2003 73 78
11. J.M. Piek, P.J. van Diest, R.P. Zweemer, J.W. Jansen, R.J. Poort-Keesom, and F.H. Menko Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer J Pathol 195 2001 451 456
12. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64
13. J.D. Lamb, R.L. Garcia, B.A. Goff, P.J. Paley, and E.M. Swisher Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy Am J Obstet Gynecol 194 2006 1702 1709
14. R. Manchanda, A. Abdelraheim, M. Johnson, A.N. Rosenthal, E. Benjamin, and C. Brunell Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status BJOG 118 2011 814 824
15. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236
16. C.B. Powell, L.M. Chen, J. McLennan, B. Crawford, C. Zaloudek, and J.T. Rabban Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol Int J Gynecol Cancer 21 2011 846 851
17. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 2007 3985 3990
18. D.W. Kindelberger, Y. Lee, A. Miron, M.S. Hirsch, C. Feltmate, and F. Medeiros Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169
19. M.H. Roh, D. Kindelberger, and C.P. Crum Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33 2009 376 383
20. C.P. Crum, R. Drapkin, A. Miron, T.A. Ince, M. Muto, and D.W. Kindelberger The distal fallopian tube: a new model for pelvic serous carcinogenesis Curr Opin Obstet Gynecol 19 2007 3 9
21. A.K. Folkins, E.A. Jarboe, A. Saleemuddin, Y. Lee, M.J. Callahan, and R. Drapkin A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations Gynecol Oncol 109 2008 168 173
22. M.H. Roh, Y. Yassin, A. Miron, K.K. Mehra, M. Mehrad, and N.M. Monte High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression Mod Pathol 23 2010 1316 1324
23. J.M. Piek, R.H. Verheijen, P. Kenemans, L.F. Massuger, H. Bulten, and P.J. van Diest BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis Gynecol Oncol 90 2003 491
24. B.M. Norquist, R.L. Garcia, K.H. Allison, C.H. Jokinen, L.E. Kernochan, and C.C. Pizzi The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations Cancer 116 2010 5261 5271
25. M.L. Carcangiu, P. Radice, S. Manoukian, G. Spatti, M. Gobbo, and V. Pensotti Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers Int J Gynecol Pathol 23 2004 35 40
26. I. Yanai-Inbar, S. Siriaunkgul, and S.G. Silverberg Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential? Int J Gynecol Pathol 14 1995 107 113
27. P.A. Shaw, M. Rouzbahman, E.S. Pizer, M. Pintilie, and H. Begley Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers Mod Pathol 22 2009 1133 1138
28. K. Visvanathan, R. Vang, P. Shaw, A. Gross, R. Soslow, and V. Parkash Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study Am J Surg Pathol 35 2011 1766 1775
29. M. Sogaard, S.K. Kjaer, and S. Gayther Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention Acta Obstet Gynecol Scand 85 2006 93 105
30. Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy Gynecol Oncol 98 2005 179 181
31. E. Leblanc, F. Narducci, I. Farre, J.P. Peyrat, S. Taieb, and C. Adenis Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development Gynecol Oncol 121 2011 472 476
32. M.H. Greene, P.L. Mai, and P.E. Schwartz Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 204 2011 19.e1 19.e6
33. J.T. Rabban, E. Krasik, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol Am J Surg Pathol 33 2009 1878 1885
34. C.B. Powell, E. Kenley, L.M. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132
35. R.I. Olivier, M. van Beurden, M.A. Lubsen, M.A. Rookus, T.M. Mooij, M.J. van de Vijver, and L.J. van't Veer Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up Br J Cancer 90 2004 1492 1497